NCT06715644View on ClinicalTrials.gov

ROX Index Versus MROX Index to Predict Treatment Outcome for High Flow Nasal Cannula And/or Noninvasive Ventilation in Patients with Respiratory Failure

Not yet recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2027

Study Completion Date

February 1, 2027

Conditions
Respiratory Failure
All Listed Sponsors
lead

Assiut University

OTHER

NCT06715644 - ROX Index Versus MROX Index to Predict Treatment Outcome for High Flow Nasal Cannula And/or Noninvasive Ventilation in Patients with Respiratory Failure | Biotech Hunter | Biotech Hunter